Product
CORT125236
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase I Adaptive Dose, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered CORT125236 in Healthy Subjects, With an Optional Pharmacological Effects CohortStatus: Completed, Estimated PCD: 2023-02-03